HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Some aspects of treatment and habilitation of children and adolescents with autistic disorder in Northern-Finland.

Abstract
Hospital records and data on the treatment/habilitation status of 187 children with autism aged 3-18 years were gathered from Northern Finland. The treatment programs and therapies varied, depending on the trained staff available. One-hundred and fifty-two (82.9%) children and adolescents with autism received more than one therapeutic intervention or specific training program. The most common therapies were physiotherapy as well as speech, occupational and music therapy. 43.9% of the children and adolescents with autism received specific training according to TEACCH (Treatment and Education of Autistic and related Communication-Handicapped Children), 10.2% according to Lovaas and 30.5% according to the Portage program. Antiepileptic medication had been prescribed to 23.9% and psychopharmacological interventions to 14.9% of the individuals with autistic disorder (AD). One hundred and seventy-eight subjects out of 187 showed some improvement on the Childhood Autism Rating Scale (CARS), even if no statistically significant difference was found between the outcome of the available habilitation methods.
AuthorsMarko Kielinen, Sirkka-Liisa Linna, Irma Moilanen
JournalInternational journal of circumpolar health (Int J Circumpolar Health) Vol. 61 Suppl 2 Pg. 69-79 ( 2002) ISSN: 1239-9736 [Print] United States
PMID12585822 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticonvulsants
Topics
  • Adolescent
  • Anticonvulsants (therapeutic use)
  • Autistic Disorder (classification, complications, drug therapy, rehabilitation, therapy)
  • Child
  • Child, Preschool
  • Epilepsy (complications, drug therapy)
  • Female
  • Finland
  • Humans
  • Male
  • Patient Education as Topic
  • Perception
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: